Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Dare Bioscience (DARE) Revenue (2016 - 2025)

Dare Bioscience (DARE) has disclosed Revenue for 9 consecutive years, with $2262.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Revenue fell 94.57% year-over-year to $2262.0, compared with a TTM value of -$57130.0 through Sep 2025, down 103.04%, and an annual FY2024 reading of $9784.0, down 99.65% over the prior year.
  • Revenue was $2262.0 for Q3 2025 at Dare Bioscience, up from -$21172.0 in the prior quarter.
  • Across five years, Revenue topped out at $10.0 million in Q2 2022 and bottomed at -$63647.0 in Q4 2024.
  • Average Revenue over 4 years is $1.3 million, with a median of $23932.5 recorded in 2024.
  • Peak annual rise in Revenue hit 173.35% in 2025, while the deepest fall reached 194.36% in 2025.
  • Year by year, Revenue stood at $10.0 million in 2022, then tumbled by 81.92% to $1.8 million in 2023, then tumbled by 103.52% to -$63647.0 in 2024, then skyrocketed by 103.55% to $2262.0 in 2025.
  • Business Quant data shows Revenue for DARE at $2262.0 in Q3 2025, -$21172.0 in Q2 2025, and $25427.0 in Q1 2025.